Amsterdam-based OLVG Lab first in Europe to use autonomous blood drawing robots

Collaborating to make healthcare more efficient

Blood tests are a key part of diagnostics, determining 70% of the decisions doctors make. With an ageing population and shortage of staff, the strain on medical personnel is only increasing. In Amsterdam, leading Dutch laboratory group OLVG Lab is addressing this issue by being the first to sign on to use fully autonomous blood collection robots developed by Utrecht-based Vitestro.

OLVG Lab has been involved in the development of these devices since 2018, along with several other Dutch laboratories. The device uses infrared to locate the vein, after which a 3D reconstruction of the blood vessel and AI-based and ultrasound-guided robotic needle determine the ideal puncture site on a precise level. This ensures accurate and consistent blood collection that can be done independently, or under the supervision of trained staff. 

Pioneers in new technology

The technology has already been successfully tested among patients and blood drawing staff at OLVG hospital. Once a CE mark is granted, the devices are set to be widely implemented in 2024. This will help relieve pressure on busy blood collection outpatient facilities. In preparation for the new way of working, OLVG staff have already taken part in Vitestro Academy, where they are trained on how to use the innovation safely and reshape their workflow.

Connections that extend through the region and beyond

The life sciences and health ecosystem in Amsterdam benefits from close connections within the region and beyond. This partnership is just one example of how knowledge and technology is developed and implemented inter-regionally to cultivate future solutions. Taking a collaborative approach has helped the Netherlands become one of Europe’s most competitive business ecosystems, making it the perfect location to bring innovative ideas to life.

Learn more about the thriving life science and health ecosystem in the Amsterdam Area.